Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 0 | 22,488 |
| Cost of Goods | N/A | N/A | N/A | N/A | 20,159 |
| Gross Profit | N/A | N/A | N/A | N/A | 2,329 |
| Operating Expenses | 20,092 | 16,987 | 27,593 | 29,502 | 116,337 |
| Operating Income | -20,092 | -16,987 | -27,593 | -29,502 | -113,849 |
| Interest Expense | 0 | 5 | 378 | 1,780 | 2,128 |
| Other Income | 740 | 824 | 273 | 24 | 17,724 |
| Pre-tax Income | -19,352 | -16,168 | -27,698 | -31,258 | -98,254 |
| Income Tax | N/A | -1 | -11,527 | N/A | -17,244 |
| Net Income Continuous | -19,352 | -16,167 | -16,171 | -31,258 | -81,011 |
| Net Income Discontinuous | N/A | N/A | 38,399 | -2,052 | N/A |
| Minority Interests | 9 | N/A | -751 | -653 | -125 |
| Net Income | $-19,361 | $-16,167 | $22,979 | $-32,656 | $-80,886 |
| EPS Basic Total Ops | -28.19 | -25.04 | 38.38 | -74.81 | -249.93 |
| EPS Basic Continuous Ops | -28.10 | -25.02 | -26.69 | -71.06 | -250.37 |
| EPS Basic Discontinuous Ops | N/A | N/A | 65.07 | -3.75 | N/A |
| EPS Diluted Total Ops | -28.19 | -25.04 | 38.38 | -74.81 | -249.93 |
| EPS Diluted Continuous Ops | -28.10 | -25.02 | -26.69 | -71.06 | -250.37 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 65.07 | -3.75 | N/A |
| EPS Diluted Before Non-Recurring Items | -28.19 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-19,795 | $-16,480 | $-26,881 | $-29,052 | $-48,794 |